Key result
LMWH represents the preferred treatment for VTE during pregnancy, while coumarins remain contraindicated until delivery.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Low-molecular-weight heparins are generally preferred for the treatment of venous thromboembolism in pregnant women. Coumarins are contraindicated in pregnancy but can be used after delivery.
No takes yet. Share an insight, caveat, or question.
Ian A. Greer (2015) studied this question. Low-molecular-weight heparins are preferred for treating venous thromboembolism during pregnancy, whereas coumarins are contraindicated until after delivery.
Synapse has enriched 10 related papers. Consider them for comparative context: